Bir sonraki

Otomatik oynatma

Managing Avelumab Side Effects in Patients With Merkel Cell Carcinoma

2 Görünümler • 07/17/23
Pay
gömmek
administrator
administrator
Aboneler
0

Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses the adverse event profile of avelumab (Bavencio) for patients with Merkel cell carcinoma.

Daha fazla göster
0 Yorumlar sort Göre sırala
Facebook Yorumları

Bir sonraki

Otomatik oynatma